Milá de la Roca Organization

The Milá de la Roca Organization is a private Venezuelan scientific institution that develops new experimental tests, new methods and new products to fight against oncologic and degenerative diseases that affect a great percentage of the world’s population.

Our experimental developments have been independently made during 33 years. We have also made clinical scientific studies in some universities of Venezuela, the US and other countries about the effect of the N-102®™ Protein.

Nowadays, we develop important scientific tests, at a genetic and molecular level that will change your future quality of life in a very positive way.

Our mission is to investigate and develop scientific therapies of cellular regeneration, applying physics to genetics, to fight efficiently against the most important health problems that affect humanity.

Our vision is to consolidate and place our organization as the supplier of the best treatment against oncologic diseases based on cellular regeneration; through the effect of the N-102®™ Protein on the codification of the DNA and ARN molecules in cancerized or degenerated cells.

The theoretical platform that supports our investigations is based on important experiments carried in the past by out-standing researchers and scientists. Among those Thyndall, Wilckle, Crawford, Lavoisier and Laplace (founders of the method of Calorimetry) and Bose, Einstein, Fermi, Dirac, Carnot, Schrödinger, Krebs y Boltzman, among others.

History:

In 1972, the Venezuelan scientist Alberto Milá de la Roca Figueras, founder of this experimental center, began to develop studies and calculations about the thermodynamics of the living cells. The experience that led him to start these studies was the demise of his mother Angela Figueras de Milá de la Roca, who suffered from cancer.

During the following 10 years, he investigated and developed scientific experiments in different cities of Venezuela and other countries of the world.

In the year of 1982, after the ending of his initial tests and calculations, the scientist Alberto Milá de la Roca Figueras discovered the N-102®™ Protein. Later on, a discreet experimentation was done with animals and vegetables in a Venezuelan city located in the State of Yaracuy. And in the same year they made first test on human beings.

The initial trials of the N-102®™ Protein were developed in animals like cats, dogs, rabbits, horses and mice, as well as, in different kinds of plants, Fruit-bearing trees, and flowers, among others.

From the year 1982 up to the year 2005, many clinical studies have been developed achieving a total, and in some cases partial, remission in the clinical diagnostics of many people who suffered from degenerative and neoproliferative diseases.

In November, 1999 we obtained the Golden Medal as the best invention in Eureka (VI Salon of inventors and innovators).

In the year 2000, we began our procedures in the US, specifically in New York